Anticipated Release Date: Q4FY23
The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) is seeking to establish an integrator for evaluating innovative medical countermeasure (MCM) technologies to meet critical unmet needs in combating CBRN threats. Staying ahead of an evolving threat landscape requires incorporating novel approaches to ensure a robust, agile, and efficient MCM development pipeline. Technologies of interest are those aimed at significantly enhancing MCM performance, accelerating development timelines, and improving success rate and speed of response to biological threats.
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.